Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 280

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Comparing HIV‐1 and HIV‐2 infection: Lessons for viral immunopathogenesis

Nyamweya, Samuel, Hegedus, Andrea, Jaye, Assan, Rowland‐Jones, Sarah, Flanagan, Katie L., Macallan, Derek C.·2013·Reviews in Medical Virology

Abstract

SUMMARY: HIV‐1 and HIV‐2 share many similarities including their basic gene arrangement, modes of transmission, intracellular replication pathways and clinical consequences: both result in AIDS. However, HIV‐2 is characterised by lower transmissibility and reduced likelihood of progression to AIDS. The underlying mechanistic differences between these two infections illuminate broader issues of retroviral pathogenesis, which remain incompletely understood. Comparisons between these two infections from epidemiological, clinical, virologic and immunologic viewpoints provide a basis for hypothesis generation and testing in this ‘natural experiment’ in viral pathogenesis. In terms of epidemiology, HIV‐2 remains largely confined to West Africa, whereas HIV‐1 extends worldwide. Clinically, HIV‐2 infected individuals seem to dichotomise, most remaining long‐term non‐progressors, whereas most HIV‐1 infected individuals progress. When clinical progression occurs, both diseases demonstrate very similar pathological processes, although progression in HIV‐2 occurs at higher CD4 counts. Plasma viral loads are consistently lower in HIV‐2, as are average levels of immune activation. Significant differences exist between the two infections in all components of the immune system. For example, cellular responses to HIV‐2 tend to be more polyfunctional and produce more IL‐2; humoral responses appear broader with lower magnitude intratype neutralisation responses; innate responses appear more robust, possibly through differential effects of tripartite motif protein isoform 5 alpha. Overall, the immune response to HIV‐2 appears more protective against disease progression suggesting that pivotal immune factors limit viral pathology. If such immune responses could be replicated or induced in HIV‐1 infected patients, they might extend survival and reduce requirements for antiretroviral therapy. Copyright © 2013 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/rmv.1739

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 280

Metadata

Authors
Nyamweya, S., Hegedus, A., Jaye, A., Rowland‐Jones, S., Flanagan, K. L., & Macallan, D. C.
Venue
Reviews in Medical Virology
Publisher
Wiley
Published
2013-02-26
Volume
23
Issue
4
Pages
221-240
ISSN
  • 1052-9276 (ISSN-L)
  • 1099-1654
OpenAlex
W1649237445
Cited by
280
References
66
FWCI
6.48
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.